No one really knew whether mass spectrometry was up to the task of population screening. Could the instruments cope with the tens-of-thousands of dried blood spots that needed to be analyzed every year? In the mid 1990s, Dr. Mike Morris began working with newborn screening labs around the world to try and answer these questions.